Article
Hepatitis C genotype 4 therapy: increasing options and improving outcomes.
Liver international : official journal of the International Association for the Study of the Liver - 1 Jan 2009
Kamal Sanaa M
Abstract excerpt
UNLABELLED: Hepatitis C virus genotype 4 (HCV-G4) is prevalent in the Middle East and Africa and has spread to several regions in Europe. HCV-G4 represents a major health problem in Egypt, with a prevalence rate of 13%. Recently, HCV-G4 has been spreading in Europe particularly among intravenous drug users (IDU) populations, who represent the main reservoir for HCV in Europe. This article reviews the current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
